Collaboration and License Agreements (Tables)

3 Months Ended

Mar. 31, 2015

Collaboration and License Agreements

Schedules of tables providing amounts included in the company's consolidated statement of comprehensive (loss) income attributable to transactions arising from its collaborative arrangements

	For the Three Months Ended March 31, 2015 (in thousands)
	2003 Sandoz Collaboration		2006 Sandoz Collaboration		Baxter Agreement		Total Collaborations
Collaboration revenues:
Product revenue	$	2,722	$	—	$	—	$	2,722
Research and development revenue:
Amortization of upfront payments	—		—		1,686		1,686
Research and development services and external costs	251		684		3,219		4,154
Total research and development revenue	$	251	$	684	$	4,905	$	5,840
Total collaboration revenues	$	2,973	$	684	$	4,905	$	8,562
Operating expenses:
Research and development expense (1)	$	31	$	148	$	608	$	787
General and administrative expense (1)	$	110	$	77	$	406	$	593
Total operating expenses	$	141	$	225	$	1,014	$	1,380

	For the Three Months Ended March 31, 2014 (in thousands)
	2003 Sandoz Collaboration		2006 Sandoz Collaboration		Baxter Agreement		Total Collaborations
Collaboration revenues:
Product revenue	$	4,812	$	—	$	—	$	4,812
Research and development revenue:
Amortization of upfront payments	—		239		803		1,042
Research and development services and external costs	323		190		4,418		4,931
Total research and development revenue	$	323	$	429	$	5,221	$	5,973
Total collaboration revenues	$	5,135	$	429	$	5,221	$	10,785
Operating expenses:
Research and development expense (1)	$	19	$	296	$	4,817	$	5,132
General and administrative expense (1)	$	9	$	143	$	30	$	182
Total operating expenses	$	28	$	439	$	4,847	$	5,314

(1) The amounts represent external expenditures, including amortization of an intangible asset, and exclude salaries and benefits, share-based compensation, facilities, depreciation and laboratory supplies, as these costs are not directly charged to programs.